# Pravastatin to Prevent Preeclampsia

> **NCT03944512** · PHASE3 · TERMINATED · sponsor: **The George Washington University Biostatistics Center** · enrollment: 102 (actual)

## Conditions studied

- Preeclampsia
- Obstetric Labor Complications
- Hypertension in Pregnancy

## Interventions

- **DRUG:** Pravastatin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03944512
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-17
- **Primary completion:** 2021-06-06
- **Final completion:** 2024-06-20
- **Target enrollment:** 102 (ACTUAL)
- **Why stopped:** participants are no longer being examined or receiving intervention
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03944512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03944512, "Pravastatin to Prevent Preeclampsia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03944512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*